EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles

Claudia M Salgado, Rita Alaggio, Andrea Ciolfi, Angelica Zin, Francesca Diomedi Camassei, Lucia Pedace, Giuseppe Maria Milano, Annalisa Serra, Angela Di Giannatale, Angela Mastronuzzi, Andrea Gianatti, Gianni Bisogno und 5 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2022.100039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Claudia M Salgado und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Kidney Neoplasms, Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pediatric population, BCL6-correpresor gene (BCOR)-upregulated tumors include primitive myxoid mesenchymal tumors/undifferentiated sarcomas (PMMTI/UND), clear cell sarcomas of the kidney (CCSK), and high-grade neuroepithelial tumors (HG-NET). We investigated DNA methylation (DNAm) and copy number variation (CNV) profiling in these tumors (N = 34) using an Illumina EPIC BeadChip to better define the potential use of these tools to confirm diagnosis and predict outcomes. Twenty-seven tumors from 25 patients (age range, 0-10 years), showed molecular confirmation of genetic abnormalities as follows: BCOR internal tandem duplication in 14 PMMTI/UND, 8 CCSK, and 3 HG-NET and YWHAE fusions in 2 PMMTI/UND. The remaining 7 cases lacking informative molecular data were analyzed by immunophenotyping and were included in the study as a training cohort, clearly separated from the main study group. These were 4 PMMTI, 1 HG-NET, and 1 CCSK in which poor RNA preservation precluded the confirmation of BCOR rearrangements and 1 CCSK in which no rearrangements were found. DNAm data were compared with those of brain tumor and/or sarcoma classifier. Differentially methylated regions (DMRs) were analyzed in the 3 groups. Twenty-two cases of the 24 molecularly confirmed PMMTI/UND and CCSK and 3 of 6 of those with only immunophenotyping were classified within the methylation class "BCOR-altered sarcoma family" with optimal calibrated scores. PMMTI/UND and CCSK showed similar methylation profiles, whereas thousands of DMRs and significantly enriched pathways were evident between soft tissue/kidney tumors and HG-NET. The CNV analysis showed an overall flat profile in 19 of the 31 evaluable tumors (8/10 CCSK; 9/18 PMMTI/UND; 2/4 HG-NET). The most frequent CNVs were 1q gain and 9p and 10q loss. Follow-up time data were available for 20 patients: ≥2 CNV significantly correlated with a worse overall survival rate. In conclusion, soft tissue and kidney BCOR sarcomas matched with BCOR-altered sarcoma methylation class, whereas those from the brain matched with the central nervous system tumor classifier HG-NET BCOR, supporting the notion that DNAm profiling is an informative diagnostic tool. CNV alterations were associated with a more aggressive clinical behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsSarcomaSoft Tissue NeoplasmsChildHumansInfant, NewbornInfantChild, PreschoolDNA MethylationDNA Copy Number VariationsKidneyProto-Oncogene ProteinsRepressor Proteins

Stichwörter der Autor:innen

BCORDNA methylationdiagnosispediatric sarcomasurvival

Substanzen

BCOR protein, humanProto-Oncogene ProteinsRepressor Proteins

Autor:innen und Institutionen

  • Division of Pathology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Pathology Unit, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. Electronic address: rita.alaggio@opbg.net.
  • Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
  • Clinica di Oncoematologia Pediatrica Azienda Ospedaliera, Università di Padova, Padova, Italy.
  • Pathology Unit, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
  • Department of Pediatric Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.

Zitieren

APA

Salgado, C. M., Alaggio, R., Ciolfi, A., Zin, A., Diomedi Camassei, F., Pedace, L., Milano, G. M., Serra, A., Di Giannatale, A., Mastronuzzi, A., Gianatti, A., Bisogno, G., Ferrari, A., Tartaglia, M., Reyes-Múgica, M., Locatelli, F., & Miele, E. (2023). Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles. Modern Pathology. https://doi.org/10.1016/j.modpat.2022.100039

Vancouver

Salgado CM, Alaggio R, Ciolfi A, Zin A, Diomedi Camassei F, Pedace L, et al. Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles. Modern Pathology. 2023. doi:10.1016/j.modpat.2022.100039

BibTeX
@article{Salgado2023,
  author = {Salgado, Claudia M and Alaggio, Rita and Ciolfi, Andrea and Zin, Angelica and Diomedi Camassei, Francesca and Pedace, Lucia and Milano, Giuseppe Maria and Serra, Annalisa and Di Giannatale, Angela and Mastronuzzi, Angela and Gianatti, Andrea and Bisogno, Gianni and Ferrari, Andrea and Tartaglia, Marco and Reyes-Múgica, Miguel and Locatelli, Franco and Miele, Evelina},
  title = {Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2022.100039}
}
Kostenlos starten →